JP Morgan Private Wealth Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,373
Closed -$226K 2028
2022
Q3
$226K Sell
4,373
-3,974
-48% -$164K ﹤0.01% 1764
2022
Q2
$207K Buy
+8,347
New +$184K ﹤0.01% 1812

Other funds holding CCXI

JP Morgan Private Wealth Advisors's CCXI Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 4,373 shares — an estimated $226K sold.

JP Morgan Private Wealth Advisors first reported a position in CCXI in Q2 2022 and held it in 2 quarters. The position peaked at $226K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • JP Morgan Private Wealth Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 4,373 ChemoCentryx, Inc. shares in Q4 2022, an estimated $226K.
  • JP Morgan Private Wealth Advisors first reported a position in ChemoCentryx, Inc. in Q2 2022 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's ChemoCentryx, Inc. position peaked at $226K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.